Icon

ADDERALL 20 (nda011522)- (5MG;5MG;5MG;5MG)

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE TEVA WOMENS
5MG;5MG;5MG;5MG
Yes No
2021-Jan-06 Expired
None None
None No
ADDERALL® is indicated in Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
19 0 14
Total Other Developers None
Drugs with Suitability No
5MG;5MG;5MG;5MG ** ** - 1 12
NDA Sales Available Total Generic Sales Available
No 14
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ****** *** **** ******, *** *********** ***** ***** ******* ******, *********, *** **** (**) *****, ****** ****** (***) ***
****** *** ***** ********** ******** ********, *** *********** **** ******** ******, ************, ************ (**) *****, ****** ****** (***) ***
****** ******** ****** *** ******** ****** *** *********** **** ***** *** *****, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ******** ****** *** ******** ****** *** *********** * ******** ****, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ******* ******* ***************, ***. *********** **** ***** ******* **, *******, *** **** (**) *****, ****** ****** (***) ***
****** **** ***** ******* ************** *** *********** *** **** ******* ******, ******, *** ****** (**) *****, ****** ****** (***) ***
****** ***** **** *** ***** ************, ***. *********** *** ****** ******, *********, *** ****** (**) *****, ****** ****** (***) ***
****** ****** ****** ****** *************** *.*. *********** **** ************* **** *, ******, ***** ******** (**) *****, ****** ****** (***) ***
****** ****** ****** *** ****** *************** *** *********** *** * ********** **, ******* *****, *** **** (**) *****, ****** ****** (***) ***
****** ******** ******** *************** ***. *********** **** & **** ******** *******, *********, ******** (**) *****, ****** ****** (***) ***
****** ******** *** **********, ***. *********** ** ******** ******, ******, ****** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.